Is there any difference in treatment strategy between squamous and non‑squamous lung cancer?

03/2017

MUDr. Libor Havel

Pneumologická klinika 1. LF UK a Thomayerova nemocnice, Praha

SUMMARY

Lung cancer is one of the most common cancer worldwide. There is approximately 1.8 million of new lung cancer cases, and 1,6 million deaths by lung cancer. There are changes is in frequency of histologic subtypes during past two decades. Predominant histology became non-squamous non-small cell lung cancer, and majority of new therapies are related to this histologic subtype. Is there any fundamental difference in treatment strategy between squamous and non-squamous lung cancer?

KEY WORDS

squamous lung cancer, immunotherapy, PD-1, EGFR, tyrosine kinase inhibitors, angiogenesis blockers